Biden-Harris Administration Announces Action to Increase Access to Sickle Cell Disease Treatments

The Biden-Harris Administration announced today that sickle cell disease (SCD) will be the first focus of the Cell and Gene Therapy (CGT) Access Model

Powered by WPeMatico